Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

OTLK Outlook Therapeutics Inc

7,07

-0,15 (-2,08%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Outlook Therapeutics Charts.

News Outlook Therapeutics Inc

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Dienstag 28 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 15 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
Mittwoch 15 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 13 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
Montag 13 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
Donnerstag 9 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 6 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Outlook Therapeutics® to Present at the Retina World Congress 2024
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Montag 29 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Montag 15 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Outlook Therapeutics Inc News-Artikel

Ford Motor Co. (

BNP Paribas Issuance

Tecma Solutions

Inpoint Commercial Real ... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen